Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Department of Pharmacy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
J Ethnopharmacol. 2023 Jun 12;309:116297. doi: 10.1016/j.jep.2023.116297. Epub 2023 Feb 26.
Xianfang Huoming Yin (XFH) is a traditional Chinese herbal formula, which has the effect of clearing heat and detoxifying toxins, dispersing swellings, activating blood circulation, and relieving pain. It is usually applied to treat various autoimmune diseases, including Rheumatoid arthritis (RA).
The migration of T lymphocytes plays an indispensable role in the pathogenesis of RA. Our previous studies demonstrated that modified Xianfang Huoming Yin (XFHM) could modulate the differentiation of T, B, and NK cells, and contribute to the restoration of immunologic balance. It also could downregulate the production of pro-inflammatory cytokines by regulating the activation of NF-κ B and JAK/STAT signaling pathways in the collagen-induced arthritis mouse model. In this study, we want to investigate whether XFHM has therapeutic effects on the inflammatory proliferation of rat fibroblast-like synovial cells (FLSs) by interfering with the migration of T lymphocytes in vitro experiments.
High performance liquid chromatography-electrospray ionization/mass spectrometer system was used to identify the constituents of the XFHM formula. A co-culture system of rat fibroblast-like synovial cells (RSC-364 cells) and peripheral blood lymphocytes stimulated by interleukin-1 beta (IL-1β) was used as the cell model. IL-1β inhibitor (IL-1βRA) was used as a positive control medicine, and two concentrations (100 μg/mL and 250 μg/mL) of freeze-dried XFHM powder were used as intervention measure. The lymphocyte migration levels were analyzed by the Real-time xCELLigence analysis system after 24 h and 48 h of treatment. The percentage of CD3CD4 T cells and CD3CD8 T cells, and the apoptosis rate of FLSs were detected by flow cytometry. The morphology of RSC-364 cells was observed by hematoxylin-eosin staining. The protein expression of key factors for T cell differentiation and NF-κ B signaling pathway-related proteins in RSC-364 cells were examined by western-blot analysis. The migration-related cytokines levels of P-selectin, VCAM-1, and ICAM-1 in the supernatant were measured by enzyme-linked immunosorbent assay.
Twenty-one different components in XFHM were identified. The migration CI index of T cells was significantly decreased in treatment with XFHM. XFHM also could significantly downregulate the levels r of CD3CD4T cells and CD3CD8T cells that migrated to the FLSs layer. Further study found that XFHM suppresses the production of P-selectin, VCAM-1, and ICAM-1. Meanwhile, it downregulated the protein levels of T-bet, ROR γ t, IKKα/β, TRAF2, and NF-κ B p50, upregulated the expression of GATA-3 and alleviated synovial cells inflammation proliferation, contributing to the FLSs apoptosis.
XFHM could attenuate the inflammation of synovium by inhibiting T lymphocyte cell migration, regulating differentiation of T cells through modulating the activation of the NF-κ B signaling pathway.
仙方活命饮(XFH)是一种中药方剂,具有清热解毒、消肿散结、活血化瘀、止痛的功效。它通常用于治疗各种自身免疫性疾病,包括类风湿关节炎(RA)。
T 淋巴细胞的迁移在 RA 的发病机制中起着不可或缺的作用。我们之前的研究表明,改良仙方活命饮(XFHM)可以调节 T、B 和 NK 细胞的分化,有助于恢复免疫平衡。它还可以通过调节 NF-κ B 和 JAK/STAT 信号通路的激活来下调致炎细胞因子的产生,在胶原诱导的关节炎小鼠模型中。在这项研究中,我们希望通过体外实验研究 XFHM 是否通过干扰 T 淋巴细胞的迁移对大鼠成纤维样滑膜细胞(FLSs)的炎症增殖具有治疗作用。
采用高效液相色谱-电喷雾电离/质谱联用系统鉴定 XFHM 配方中的成分。采用白细胞介素-1β(IL-1β)刺激的大鼠成纤维样滑膜细胞(RSC-364 细胞)和外周血淋巴细胞的共培养系统作为细胞模型。采用白细胞介素-1β抑制剂(IL-1βRA)作为阳性对照药物,采用两种浓度(100μg/ml 和 250μg/ml)的冻干 XFHM 粉末作为干预措施。在治疗 24 小时和 48 小时后,通过实时 xCELLigence 分析系统分析淋巴细胞迁移水平。通过流式细胞术检测 CD3CD4 T 细胞和 CD3CD8 T 细胞的百分比和 FLSs 的凋亡率。通过苏木精-伊红染色观察 RSC-364 细胞的形态。通过 Western-blot 分析检测 RSC-364 细胞中 T 细胞分化关键因子和 NF-κ B 信号通路相关蛋白的表达。通过酶联免疫吸附试验测定上清液中 P-选择素、VCAM-1 和 ICAM-1 的迁移相关细胞因子水平。
XFHM 中鉴定出 21 种不同的成分。XFHM 处理后 T 细胞的迁移 CI 指数明显降低。XFHM 还可以显著下调迁移到 FLSs 层的 CD3CD4T 细胞和 CD3CD8T 细胞的水平。进一步的研究发现,XFHM 抑制 P-选择素、VCAM-1 和 ICAM-1 的产生。同时,它下调 T-bet、ROR γ t、IKKα/β、TRAF2 和 NF-κ B p50 的蛋白水平,上调 GATA-3 的表达,减轻滑膜细胞炎症增殖,促进 FLSs 凋亡。
XFHM 通过抑制 T 淋巴细胞迁移,调节 NF-κ B 信号通路的激活,调节 T 细胞的分化,从而减轻滑膜炎症。